Invention Grant
- Patent Title: Mammalian alveolar macrophages derived from pluripotent cells
-
Application No.: US15672432Application Date: 2017-08-09
-
Publication No.: US11001806B2Publication Date: 2021-05-11
- Inventor: Martin Post , Michael Litvack
- Applicant: The Hospital for Sick Children
- Applicant Address: CA Toronto
- Assignee: The Hospital for Sick Children
- Current Assignee: The Hospital for Sick Children
- Current Assignee Address: CA Toronto
- Agency: Gowling WLG (Canada) LLP
- Agent Susan Tandan
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/0786 ; A61K35/15 ; C12N5/0735

Abstract:
Alveolar-like macrophages and a method for generating alveolar-like macrophages from hemangioblasts is provided. The method comprises the steps of: i) culturing the hemangioblasts in a hematopoietic-inducing medium comprising vascular endothelial growth factor (VEGF), stem cell factor (SCF) and interleukin-3 (IL-3) for a sufficient period of time to generate macrophages, and ii) culturing the macrophages in an alveolar macrophage-inducing medium comprising granulocyte macrophage colony stimulating factor (GM-CSF), and optionally macrophage colony stimulating factor (M-CSF), under suitable conditions and for a sufficient period of time to yield alveolar-like macrophages.
Public/Granted literature
- US20170335282A1 ALVEOLAR-LIKE MACROPHAGES AND METHOD OF GENERATING SAME Public/Granted day:2017-11-23
Information query